Avacta Group (LON:AVCT) Stock Passes Below 200-Day Moving Average – Here’s Why

Avacta Group Plc (LON:AVCT)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 64.69 and traded as low as GBX 63. Avacta Group shares last traded at GBX 65, with a volume of 7,330,272 shares.

Avacta Group Stock Performance

The firm’s 50 day simple moving average is GBX 61.61 and its 200-day simple moving average is GBX 64.69. The company has a debt-to-equity ratio of 14,168.75, a quick ratio of 4.96 and a current ratio of 0.79. The company has a market capitalization of £284.46 million, a price-to-earnings ratio of -3.70 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).